MYOGENESIS INVOLVES A COMPLEX SERIES of signaling events that will result in the formation of muscle fibers (3). The participation of nitric oxide (NO) in myogenesis has been evidenced over the years. Most of the endogenous production of NO in skeletal muscle comes from the neuronal isoform of the NO synthase (nNOS) (5). Subcellular compartmentalization of nNOS is essential to enable site-specific generation of NO and signaling through cGMP production and S-nitrosylation of proteins in skeletal muscle (8). It was earlier suggested that in skeletal muscle, nNOS interacts with two domains of caveolin-3, which is part of caveolae, an invagination of the sarcolemma. At the caveolae, nNOS and caveolin-3 form a signaling complex through additional interactions with Src kinase and p21Ras (8).
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Specific NO targets in skeletal muscle development include the ryanodine receptor calcium release channel (Ryr) and soluble guanylyl cyclase (sGC). Xu et al. (9) showed that Ryr purified from canine hearts was endogenously S-nitrosylated. In myoblasts, the mechanisms by which NO acts during the transition between myoblast proliferation and fusion have been reported to be regulated by a transient generation of cGMP (4) . Most importantly, sGC activity potentially is downregulated by S-nitrosylation (6) . S-nitrosylation, which is characterized by the covalent attachment of a NO group to a Cys thiol side chain, regulates the cellular responses mediated by ligand-gated ion channels, G protein-coupled receptors, cytokine receptors, and receptor tyrosine kinases. In the context of signal transduction, reversibility of S-nitrosylation is achieved through denitrosylation of S-nitrosoglutathione (GSNO) and S-nitrosylated proteins, which is carried out by two specific enzymatic systems: the thioredoxin/thioredoxin reductase system and the GSH/GSNO reductase (GSNOR) system (1).
GSNO is the most physiologically relevant S-nitrosothiol (SNO) initially isolated in human airways. GSNO is formed in cells by the reaction between NO (or another SNO) with GSH, or through GSH-mediated denitrosylation of S-nitrosylated proteins and other cellular SNOs. The metabolism of GSNO is carried out by the GSNOR, an evolutionary conserved and widely expressed enzyme in prokaryotic and eukaryotic organisms. GSNOR specifically catalyzes the denitrosylation of GSNO. Nevertheless, studies using GSNOR knockouts in yeast and in mammalian cells clearly indicated that GSNO is in equilibrium with S-nitrosylated proteins (1) .
In a recent issue of the American Journal of PhysiologyCell Physiology, Yamashita and coworkers (10) convincingly demonstrate that in primary cultures of chick embryonic skeletal muscle cells, the effects of NO on myogenesis are importantly mediated by S-nitrosylation/denitrosylation. Another important conclusion drawn from the studies was the role played by nNOS as the solely NO source in myogenesis. Together with GSNOR, nNOS activity was shown to determine intracellular SNO levels. Indeed, pharmacological inhibition or knockdown of GSNOR on myoblasts promoted an increase on the SNO levels during myogenesis. On the other hand, inhibition of nNOS strongly inhibited the generation of SNO in myoblasts. Increasing intracellular SNO levels during myogenesis stimulates cell proliferation in both myoblasts and fibroblasts and diminishes myoblast fusion. Importantly, the authors also demonstrate that myoblast fusion occurred only after an increase in GSNOR activity. In addition, by stimulating myoblasts with CysNO, Yamashita et al. were able to recapitulate the proproliferative effects derived from the enhanced intracellular SNO levels. Most important, Yamashita et al. showed for the first time that NO-stimulated myoblast proliferation occurs without the participation of cGMP. However, fibroblasts behaved like other cells and cGMP levels have to rise for SNO-induced proliferation to proceed. Yamashita et al. also demonstrated that an increase in the intracellular SNO pool drives myoblast proliferation but not fusion. Their findings clearly indicate that optimal intracellular SNO levels have to be maintained to regulate proliferation of myoblasts and their differentiation to myotubes.
The use of primary cultures of skeletal muscle progenitor cells from chick embryos by Yamashita et al. provides an environmental condition that is similar to the in vivo condition. These primary cultures contain both myoblasts and fibroblasts, which proliferate in different phases of myogenesis. Myoblasts proliferate before they withdraw from the cell cycle to fuse, forming myotubes, whereas fibroblasts will continuously proliferate (3) . Although the data presented support a major role for NO and S-nitrosylation as key regulators of myoblast proliferation, some questions related to the signaling pathway associated with the NO/ SNO-driven proliferation of myoblasts remain unanswered. The first question was asked by the authors when they suggested that p21Ras could be trans-nitrosylated and activated by GSNO, triggering cell cycle progression and proliferation (7). Second, could S-nitrosylation and activation of Src kinase be important to the overall mechanism of NO/SNO-induced proliferation of myoblast? S-nitrosylation of Src kinase was earlier shown to be important for the assembling of the focal adhesion complex in mouse fibroblasts, stimulating their proliferation (2) . S-nitrosylated Src and p21Ras, nNOS, and caveolin-3 (2, 7, 8) could be organized as a signaling complex that is associated with myoblast proliferation. A general scheme of this putative signaling complex is shown in Fig. 1 .
In summary, Yamashita et al. present compelling evidence that manipulation of GSNOR activity with consequent modulation of the intracellular S-nitrosylation levels in myoblasts is important for myoblast proliferation and fusion. These findings may have consequences for the promotion of muscle repair and prevention of skeletal muscle wasting.
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